China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Porus Trigeminus Based on Radiomics: Exploring Imaging Biomarkers for Pr... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Application of Orthopedic Robots Combined with 3D Printing in Spinal Tum... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Relationship Between Lipoprotein(a) and Coronary Stenosis as well as Clinical Stabil... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of high protein nutritional intervention nutrition on muscle mass in patients wit... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of Visual Fatigue on Postural Control and Sensory Integration Strategies in Indi... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Compound Betamethasone Versus Dexamethasone in CT-Guided Selectiv... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Risk factors investigation for pulmonary complications after thoracoscopic pulmonary nod... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy of Teprotumumab N01 Injection in Patients with Thyroid Eye Disease Refractory t... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects and Underlying Mechanisms of Personalized Music Interventions for Depressive Sym... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Screening for non-alcoholic fatty liver disease and intervention therapy with growth hor... Read More